
AstraZeneca to build 1.5 billion USD cancerꦆ drug facility🎃 in Singapore
British pharmaceutical company AstraZeneca announced on May 20 its intention to build a 1.5 billion USD facility in Singapore to produce new generation cancer treatment drugs.